Testing new antiviral treatments using lab-grown viruses.
Official title: TASK B26: COMPREHENSIVE VIRAL SCREENING PANEL.
Funded at Utah State University · NIH-11299955 · Data updated 2026-11-12
This study is looking for new antiviral medicines by testing them in the lab to see how well they work against different viruses, which could help people who are dealing with viral infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State University NIH-funded |
| Lab location | 1 site (Logan, United States) |
| Project start | December 16, 2024 |
| Project end | December 15, 2025 |
| Funding year | 2025 |
| Award (this year) | $372,870 |
| NIH project number | 75N93019D00021-0-759302500001-1 |
| Project ID | NIH-11299955 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from viral infections or those at risk of contracting communicable diseases.
✕Less likely to help
Patients with non-viral infections or those who do not have access to antiviral treatments may not receive any benefit from this research.
What this research studies
This research focuses on evaluating potential antiviral agents through in vitro testing, which means that the tests are conducted in a controlled laboratory environment using cultured cell lines. The project involves maintaining viral stocks and developing assays to measure the effectiveness of these antiviral compounds against various viruses. Patients may benefit from this research as it aims to identify new treatments for infectious diseases caused by viruses.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral medications that improve treatment options for patients with viral infections.
How similar studies have gone: Previous research has shown success in developing antiviral agents through similar in vitro testing approaches, indicating a promising avenue for new treatment options.
Where this research is happening
-
Utah State University
Logan, United States Active
Researchers
- Principal investigator: Julander, Justin — Utah State University
- Study coordinator: Julander, Justin
Related research
Other NIH-funded projects on the same topics.
-
Advancing antiparasitic drugs for sheep, goats, and bison
A funding opportunity to develop new antiparasitic medicines for food-producing small ruminants like sheep and goats, addressing parasite resistance and limited approved options.
-
One-dose vaccine candidate for Kyasanur Forest disease (KFD) to protect people
A single-dose, live-attenuated chimeric vaccine is being developed to prevent Kyasanur Forest disease in people who may be exposed to the virus.
-
Hamster model to study hepatitis B virus infection
A researcher is creating a hamster-based model to study how hepatitis B virus infects and persists in the liver, with the goal of helping develop better treatments and cures.
-
Using social rhythm to help people with Parkinson’s talk more clearly
A small study will test whether matching someone else’s speech pace and style can help people with Parkinson’s disease speak more clearly in everyday conversations.
-
VR-SAFE: Virtual Reality Training to Help Healthcare Workers Prevent Violent Encounters
A new virtual reality training program helps healthcare workers learn skills to prevent violent encounters and stay safer on the job.
-
How bile and gut environment affect Shigella’s harmful tactics
A researcher is studying how the environment inside the gut, especially bile, changes how Shigella bacteria cause disease in people, which could lead to better treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.